[{"AccountsPayableCurrent_0_Q1_USD":13696000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-6309000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q1_USD":84378000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":11269000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":16367000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2721000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":151586000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":317920000.0,"AvailableForSaleSecuritiesGrossUnrealizedLoss_1_Q1_USD":103000.0,"AvailableForSaleSecuritiesGrossUnrealizedGains_1_Q1_USD":1318000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":593321000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":461000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":2567000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":101000.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":215295000.0,"InterestExpenseDebt_1_Q1_USD":29531000.0,"TaxesPayableCurrent_0_Q1_USD":30000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-72565000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":294863000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":14118000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":483000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":621703.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":85000.0,"OtherAssetsNoncurrent_0_Q1_USD":493000.0,"LongTermDebtNoncurrent_0_Q1_USD":73688000.0,"LongTermDebt_0_Q1_USD":106031000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":135000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":2238000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":16705000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":412000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":594536000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":2395000.0,"ReceivablesNetCurrent_0_Q1_USD":4578000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":57936000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":2099000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.087,"OperatingLeaseRightOfUseAsset_0_Q1_USD":52082000.0,"OperatingLeasePaymentsUse_1_Q1_USD":1153000.0,"OperatingLeasePayments_1_Q1_USD":7100000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":81638000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2691000.0,"OperatingLeaseLiability_0_Q1_USD":84329000.0,"OperatingLeaseCost_1_Q1_USD":3100000.0,"NoninterestIncome_1_Q1_USD":2856000.0,"NoninterestExpense_1_Q1_USD":2314000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":461000.0,"LossContingencyLossInPeriod_1_Q1_USD":0.0,"LossContingencyAccrualProvision_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":45190000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":5878000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":12116000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":12508000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":12913000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":13333000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":61035000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":129519000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-1153000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":13288000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":66.05,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1870000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":28.5,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4133721.0,"StockholdersEquity_0_Q1_USD":523572000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-811942000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":37329000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":14144000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":2524000.0,"NetIncomeLoss_1_Q1_USD":-73026000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-78622000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":91126000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":784000.0,"LiabilitiesCurrent_0_Q1_USD":62248000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":741146000.0,"Liabilities_0_Q1_USD":217574000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":60787710.0,"InventoryNet_0_Q1_USD":14927000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1941000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.2,"CostsAndExpenses_1_Q1_USD":87570000.0,"CommonStockValue_0_Q1_USD":61000.0,"CommonStockSharesOutstanding_0_Q1_shares":60886371.0,"CommonStockSharesIssued_0_Q1_shares":60886371.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":315525000.0,"AssetsCurrent_0_Q1_USD":564469000.0,"Assets_0_Q1_USD":741146000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6824880.0,"AdditionalPaidInCapital_0_Q1_USD":1334238000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1215000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":147000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":34562000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":47.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":27905.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":426000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":800000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4262000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":56160000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":11736000.0,"InventoryWorkInProcess_0_Q1_USD":7217000.0,"InventoryRawMaterials_0_Q1_USD":7141000.0,"InventoryFinishedGoods_0_Q1_USD":569000.0,"IncreaseDecreaseInInventories_1_Q1_USD":13218000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":18831000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":967000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q1_USD":-2099000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":33937.0,"ShareBasedCompensation_1_Q1_USD":16367000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":47662000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":39773000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-73452000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-6766000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":75000000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":40.72,"VariableLeaseCost_1_Q1_USD":700000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]